
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2799 | 17.2777777778 | 1.62 | 2.08 | 1.53 | 374716 | 1.68070092 | CS |
4 | 0.4999 | 35.7071428571 | 1.4 | 2.08 | 1.34 | 284036 | 1.54195017 | CS |
12 | 0.1299 | 7.33898305085 | 1.77 | 2.68 | 1.15 | 1725573 | 1.57363654 | CS |
26 | -1.1401 | -37.5032894737 | 3.04 | 3.61 | 1.15 | 1263823 | 1.88695461 | CS |
52 | -1.9641 | -50.8307453416 | 3.864 | 23.8 | 1.15 | 1390671 | 7.02000728 | CS |
156 | -73.1061 | -97.4670026398 | 75.006 | 170.1 | 1.15 | 568651 | 13.17296057 | CS |
260 | -871.1001 | -99.782371134 | 873 | 1126.782 | 1.15 | 414069 | 115.68684089 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions